Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development

Kenneth L. Johnson, Inna G. Ovsyannikova, Christopher J. Mason, H. Robert Bergen, Gregory A. Poland

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

An important approach for developing a safer smallpox vaccine is to identify naturally processed immunogenic vaccinia-derived peptides rather than live whole vaccinia virus. We used two-dimensional liquid chromatography coupled to mass spectrometry to identify 116 vaccinia peptides, encoded by 61 open reading frames, from a B-cell line (homozygous for HLA class I A*0201, B*1501, and C*03) after infection with vaccinia virus (Dryvax). Importantly, 68 of these peptides are conserved in variola, providing insight into the peptides that induce protection against smallpox. Twenty-one of these 68 conserved peptides were 11 amino acids long or longer, outside of the range of most predictive algorithms. Thus, direct identification of naturally processed and presented HLA peptides gives important information not provided by current computational methods for identifying potential vaccinia epitopes.

Original languageEnglish (US)
Pages (from-to)38-47
Number of pages10
JournalVaccine
Volume28
Issue number1
DOIs
StatePublished - Dec 10 2009

Keywords

  • Antigen presentation
  • HLA class I
  • Smallpox vaccine
  • Vaccinia virus

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development'. Together they form a unique fingerprint.

Cite this